Echinocandin

This page covers all Echinocandin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting β-(1,3)-D-glucan synthase, Glucan synthase.

Targets

β-(1,3)-D-glucan synthase · Glucan synthase

Marketed (1)

• Isauvuconazole group · Pfizer · Other

Phase 2 pipeline (1)

• MK0991, caspofungin acetate · Merck Sharp & Dohme LLC · Infectious Disease
  Inhibits the synthesis of beta-1,3-D-glucan, a critical component of fungal cell walls.